magnolol has been researched along with Injury, Ischemia-Reperfusion in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 6 (50.00) | 24.3611 |
2020's | 2 (16.67) | 2.80 |
Authors | Studies |
---|---|
Chiang, SC; Huang, CH; Huang, PC; Huang, PH; Lai, CC; Tang, CY; Tseng, KW; Yang, AH | 2 |
Gu, M; Guo, W; Huang, L; Liu, Y; Sun, H; Wang, N; Wu, Y; Xu, L; Yang, Y | 1 |
Chen, X; Liu, X; Wang, K; Wang, Y; Zhu, Y | 1 |
Chang, CC; Chang, CH; Huang, SY; Lee, EJ; Tai, SH; Tu, YF | 1 |
Li, H; Liu, X; Liu, Y; Wang, Y; Zhu, Y | 1 |
Chen, HY; Chen, TY; Chuang, IC; Hung, YC; Lee, EJ; Wu, TS | 1 |
Chang, HR; Chen, CL; Cheng, YF; Goto, S; Hsu, LW; Hung, CT; Jawan, B; Kao, YH; Lai, CY; Lin, YC; Pan, MC; Sun, CK; Tsai, CC; Wang, CS | 1 |
Huang, MS; Lee, CH; Shih, HC | 1 |
Chiu, JH; Chiu, YY; Loong, CC; Lui, WY; Tiao, RC; Wu, CW | 1 |
Chen, CL; Chen, YS; Cheng, YF; Eng, HL; Goto, S; Hsieh, SW; Jawan, B; Lai, CY; Lan, KM; Lin, YC; Luk, HN; Pan, TL; Wang, CC | 1 |
Chiu, JH; Hong, CY; Lui, WY; Wang, JC; Wu, CW | 1 |
12 other study(ies) available for magnolol and Injury, Ischemia-Reperfusion
Article | Year |
---|---|
Magnolol reduces myocardial injury induced by renal ischemia and reperfusion.
Topics: Animals; Apoptosis; Biphenyl Compounds; Interleukin-10; Interleukin-6; Ischemia; Lignans; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Sprague-Dawley; Reperfusion; Reperfusion Injury; Stroke Volume; Troponin I; Tumor Necrosis Factor-alpha; Ventricular Function, Left | 2022 |
Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Eosine Yellowish-(YS); Glaucoma; Hematoxylin; Inflammation; Ischemia; Mice; NF-kappa B; NF-KappaB Inhibitor alpha; PPAR gamma; Reperfusion Injury; Retina | 2022 |
Effect of magnolol on cerebral injury and blood brain barrier dysfunction induced by ischemia-reperfusion in vivo and in vitro.
Topics: Animals; Biphenyl Compounds; Blood-Brain Barrier; Brain Ischemia; Dose-Response Relationship, Drug; Interleukin-1beta; Lignans; Mice; Microglia; Nitric Oxide; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, EphA2; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2017 |
Magnolol Reduces Renal Ischemia and Reperfusion Injury via Inhibition of Apoptosis.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Biphenyl Compounds; Blood Urea Nitrogen; Creatinine; Dose-Response Relationship, Drug; Infusions, Intravenous; Interleukin-10; Interleukin-1beta; Interleukin-6; Ischemia; JNK Mitogen-Activated Protein Kinases; Kidney; Lignans; Male; Mitogen-Activated Protein Kinase 3; Phosphorylation; Phytotherapy; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Tumor Necrosis Factor-alpha | 2017 |
Magnolol protects against ischemic-reperfusion brain damage following oxygen-glucose deprivation and transient focal cerebral ischemia.
Topics: Animals; Antioxidants; Biphenyl Compounds; Brain; Brain Ischemia; Cell Line; Glucose; Lignans; Male; Mice; Neuroprotective Agents; Oxidative Stress; Oxygen; Rats, Sprague-Dawley; RAW 264.7 Cells; Reperfusion Injury | 2018 |
Magnolol derivative 002C-3 protects brain against ischemia-reperfusion injury via inhibiting apoptosis and autophagy.
Topics: Animals; Apoptosis; Autophagy; Biphenyl Compounds; Brain; Brain Infarction; Caspase 3; Infarction, Middle Cerebral Artery; Lignans; Male; Mice; Neuroprotective Agents; Rats, Sprague-Dawley; Reperfusion Injury | 2015 |
The protective efficacy of magnolol in hind limb ischemia-reperfusion injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biphenyl Compounds; Body Temperature; Drug Evaluation, Preclinical; Hindlimb; Lignans; Magnolia; Male; Malondialdehyde; Nitric Oxide; Peroxidase; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Reperfusion Injury | 2009 |
High concentration of magnolol induces hepatotoxicity under serum-reduced conditions.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Biphenyl Compounds; Blotting, Western; Caspase 3; Chemical and Drug Induced Liver Injury; Cold Temperature; Cryopreservation; Cytochromes c; I-kappa B Proteins; In Situ Nick-End Labeling; Lignans; Liver; Liver Transplantation; Magnolia; Male; Mitochondria; NF-kappa B; Plant Bark; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; Serum; Signal Transduction; Tumor Necrosis Factor-alpha | 2010 |
Magnolol attenuates the lung injury in hypertonic saline treatment from mesenteric ischemia reperfusion through diminishing iNOS.
Topics: Animals; Antioxidants; Biphenyl Compounds; Interleukin-6; Lignans; Lung; Male; Mesentery; Mice; Mice, Inbred C3H; Models, Animal; Nitric Oxide Synthase Type II; Peroxides; Peroxynitrous Acid; Pulmonary Edema; Regional Blood Flow; Reperfusion Injury; Saline Solution, Hypertonic; Tumor Necrosis Factor-alpha | 2012 |
Protective effect of magnolol on the small intestinal ischemia-reperfusion injury.
Topics: Animals; Anti-Arrhythmia Agents; Biphenyl Compounds; Intestinal Mucosa; Intestine, Small; Lignans; Microcirculation; Rats; Reperfusion Injury | 2002 |
The protective mechanism of magnolol, a Chinese herb drug, against warm ischemia-reperfusion injury of rat liver.
Topics: Animals; Apoptosis; bcl-X Protein; Biphenyl Compounds; Drugs, Chinese Herbal; Enzyme Inhibitors; Gene Expression Regulation; Lignans; Liver; Models, Animal; Nitric Oxide Synthase; Proto-Oncogene Proteins c-bcl-2; Rats; Reperfusion Injury | 2003 |
Effect of magnolol on in vitro mitochondrial lipid peroxidation and isolated cold-preserved warm-reperfused rat livers.
Topics: Animals; Antioxidants; Biphenyl Compounds; Cold Temperature; In Vitro Techniques; Lignans; Lipid Peroxidation; Liver; Male; Malondialdehyde; Mitochondria, Liver; Organ Preservation; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Vitamin E | 1999 |